Follow-up interval for probably benign breast lesions on screening ultrasound in women at average risk for breast cancer with dense breasts

Hee Jung Moon, minjung Kim, Jung Hyun Yoon, Eunkyung Kim

Research output: Contribution to journalArticle

Abstract

Background: Women at high risk for breast cancer and women at average risk have different pretest probabilities. Probably benign lesions on screening ultrasound (US) should be assessed and managed differently for these two risk groups. Purpose: To evaluate the effectiveness of short-term follow-up for probably benign lesions on screening US in women at average risk for breast cancer with dense breasts. Material and Methods: A total of 445 women at average risk for breast cancer with probably benign lesions on screening US, dense breasts, and negative or benign mammography results were included. Women were classified into the six-month group (n = 345) or 12-month group (n = 100) according to when the first follow-up was performed (3–9 months or 9–15 months). The cancer detection rate, frequencies of newly developed lesions and progressed lesions, and biopsy rate were compared. Results: There were no malignancies from three to 15 months. Three cancers newly developed after 15 months. One was a 3-mm ductal carcinoma in situ and two were 10-mm and 18-mm invasive ductal carcinoma without lymph node metastasis. The frequency of newly developed lesions and progressed lesions and biopsy rate were not significantly different between the six-month and 12-month groups (P = 0.320, 0.621, and >0.999). Conclusion: A follow-up at 12 months can be considered for probably benign lesions on screening US in women at average risk for breast cancer with dense breasts. However, a large series prospective study is needed before clinical application.

Original languageEnglish
Pages (from-to)1045-1050
Number of pages6
JournalActa Radiologica
Volume59
Issue number9
DOIs
Publication statusPublished - 2018 Sep 1

Fingerprint

Breast
Breast Neoplasms
Biopsy
Neoplasms
Ductal Carcinoma
Carcinoma, Intraductal, Noninfiltrating
Mammography
Lymph Nodes
Prospective Studies
Neoplasm Metastasis

All Science Journal Classification (ASJC) codes

  • Radiological and Ultrasound Technology
  • Radiology Nuclear Medicine and imaging

Cite this

@article{3cc2c57054044d7592633e08d4c94c89,
title = "Follow-up interval for probably benign breast lesions on screening ultrasound in women at average risk for breast cancer with dense breasts",
abstract = "Background: Women at high risk for breast cancer and women at average risk have different pretest probabilities. Probably benign lesions on screening ultrasound (US) should be assessed and managed differently for these two risk groups. Purpose: To evaluate the effectiveness of short-term follow-up for probably benign lesions on screening US in women at average risk for breast cancer with dense breasts. Material and Methods: A total of 445 women at average risk for breast cancer with probably benign lesions on screening US, dense breasts, and negative or benign mammography results were included. Women were classified into the six-month group (n = 345) or 12-month group (n = 100) according to when the first follow-up was performed (3–9 months or 9–15 months). The cancer detection rate, frequencies of newly developed lesions and progressed lesions, and biopsy rate were compared. Results: There were no malignancies from three to 15 months. Three cancers newly developed after 15 months. One was a 3-mm ductal carcinoma in situ and two were 10-mm and 18-mm invasive ductal carcinoma without lymph node metastasis. The frequency of newly developed lesions and progressed lesions and biopsy rate were not significantly different between the six-month and 12-month groups (P = 0.320, 0.621, and >0.999). Conclusion: A follow-up at 12 months can be considered for probably benign lesions on screening US in women at average risk for breast cancer with dense breasts. However, a large series prospective study is needed before clinical application.",
author = "Moon, {Hee Jung} and minjung Kim and Yoon, {Jung Hyun} and Eunkyung Kim",
year = "2018",
month = "9",
day = "1",
doi = "10.1177/0284185117745906",
language = "English",
volume = "59",
pages = "1045--1050",
journal = "Acta Radiologica",
issn = "0284-1851",
publisher = "SAGE Publications Ltd",
number = "9",

}

Follow-up interval for probably benign breast lesions on screening ultrasound in women at average risk for breast cancer with dense breasts. / Moon, Hee Jung; Kim, minjung; Yoon, Jung Hyun; Kim, Eunkyung.

In: Acta Radiologica, Vol. 59, No. 9, 01.09.2018, p. 1045-1050.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Follow-up interval for probably benign breast lesions on screening ultrasound in women at average risk for breast cancer with dense breasts

AU - Moon, Hee Jung

AU - Kim, minjung

AU - Yoon, Jung Hyun

AU - Kim, Eunkyung

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Background: Women at high risk for breast cancer and women at average risk have different pretest probabilities. Probably benign lesions on screening ultrasound (US) should be assessed and managed differently for these two risk groups. Purpose: To evaluate the effectiveness of short-term follow-up for probably benign lesions on screening US in women at average risk for breast cancer with dense breasts. Material and Methods: A total of 445 women at average risk for breast cancer with probably benign lesions on screening US, dense breasts, and negative or benign mammography results were included. Women were classified into the six-month group (n = 345) or 12-month group (n = 100) according to when the first follow-up was performed (3–9 months or 9–15 months). The cancer detection rate, frequencies of newly developed lesions and progressed lesions, and biopsy rate were compared. Results: There were no malignancies from three to 15 months. Three cancers newly developed after 15 months. One was a 3-mm ductal carcinoma in situ and two were 10-mm and 18-mm invasive ductal carcinoma without lymph node metastasis. The frequency of newly developed lesions and progressed lesions and biopsy rate were not significantly different between the six-month and 12-month groups (P = 0.320, 0.621, and >0.999). Conclusion: A follow-up at 12 months can be considered for probably benign lesions on screening US in women at average risk for breast cancer with dense breasts. However, a large series prospective study is needed before clinical application.

AB - Background: Women at high risk for breast cancer and women at average risk have different pretest probabilities. Probably benign lesions on screening ultrasound (US) should be assessed and managed differently for these two risk groups. Purpose: To evaluate the effectiveness of short-term follow-up for probably benign lesions on screening US in women at average risk for breast cancer with dense breasts. Material and Methods: A total of 445 women at average risk for breast cancer with probably benign lesions on screening US, dense breasts, and negative or benign mammography results were included. Women were classified into the six-month group (n = 345) or 12-month group (n = 100) according to when the first follow-up was performed (3–9 months or 9–15 months). The cancer detection rate, frequencies of newly developed lesions and progressed lesions, and biopsy rate were compared. Results: There were no malignancies from three to 15 months. Three cancers newly developed after 15 months. One was a 3-mm ductal carcinoma in situ and two were 10-mm and 18-mm invasive ductal carcinoma without lymph node metastasis. The frequency of newly developed lesions and progressed lesions and biopsy rate were not significantly different between the six-month and 12-month groups (P = 0.320, 0.621, and >0.999). Conclusion: A follow-up at 12 months can be considered for probably benign lesions on screening US in women at average risk for breast cancer with dense breasts. However, a large series prospective study is needed before clinical application.

UR - http://www.scopus.com/inward/record.url?scp=85046038504&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046038504&partnerID=8YFLogxK

U2 - 10.1177/0284185117745906

DO - 10.1177/0284185117745906

M3 - Article

VL - 59

SP - 1045

EP - 1050

JO - Acta Radiologica

JF - Acta Radiologica

SN - 0284-1851

IS - 9

ER -